1. Home
  2. CSTE vs IVVD Comparison

CSTE vs IVVD Comparison

Compare CSTE & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$0.67

Market Cap

27.7M

Sector

Industrials

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.70

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
IVVD
Founded
1987
2020
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
437.1M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
CSTE
IVVD
Price
$0.67
$1.70
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$5.00
$8.75
AVG Volume (30 Days)
2.4M
1.7M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.02
EPS
N/A
N/A
Revenue
N/A
$53,426,000.00
Revenue This Year
$3.43
$143.48
Revenue Next Year
$2.83
$25.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
110.47
52 Week Low
$0.56
$0.46
52 Week High
$3.26
$3.07

Technical Indicators

Market Signals
Indicator
CSTE
IVVD
Relative Strength Index (RSI) 20.76 46.09
Support Level N/A $1.41
Resistance Level $2.00 $1.77
Average True Range (ATR) 0.17 0.12
MACD -0.05 0.02
Stochastic Oscillator 9.45 32.93

Price Performance

Historical Comparison
CSTE
IVVD

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: